美股A股
StockGist
Back
10-Q2026-05-01· qwen-plus

PRLB · Proto Labs, Inc.

0001443669-26-000025

SEC filing

Summary

Proto Labs delivered strong Q1 FY2026 results with 10.4% revenue growth and a 125.4% increase in net income, driven by higher gross profit, operating leverage, and a one-time state tax audit benefit.

Key takeaways

Full analysis

Financial Performance

Revenue for Q1 FY2026 was $139.3 million, an increase of 10.4% compared to $126.2 million in Q1 FY2025. This growth reflects Proto Labs’ ongoing execution of its core business strategy: serving product developers, engineers, and procurement professionals with quick-turn, on-demand injection-molded, CNC-machined, 3D-printed, and fabricated sheet metal parts for prototyping and low-volume production. Management has emphasized a deliberate shift toward larger, more strategic customers — a dynamic that supports both revenue resilience and margin sustainability.

Gross profit increased 14.2% to $63.6 million, resulting in a gross margin of 45.6%. This margin level is consistent with management’s commentary on customer mix and operational discipline, including efforts to expand factory and network gross margins through efficiencies and productivity improvements.

Operating income rose sharply to $9.8 million — up 117.1% year-over-year — driven by gross profit growth and operating expense leverage. Cost savings from prior restructuring and transformation initiatives are being redeployed primarily into technology investments, including enhancements to core systems, automation, and digital capabilities, reinforcing the company’s focus on scalable, technology-enabled operations.

Net income totaled $8.1 million, an increase of 125.4% versus $3.6 million in the prior-year quarter. This improvement reflects both stronger operating performance and a one-time tax benefit arising from the successful resolution of a state income tax audit. As noted in management discussion, the decrease in the effective tax rate was also supported by increased tax benefits from the vesting of restricted stock and exercise of stock options.

Diluted earnings per share were $0.33, up 120.0% from $0.15 in Q1 FY2025, tracking closely with the growth in net income.

Cash Flow and Capital Allocation